Yes, in Lilly’s own words, with a caveat attached. The LillyDirect page lists each Zepbound presentation as “HSA/FSA eligible” and adds “Eligibility may vary by plan”[2]. The LillyDirect FAQ says its pharmacies accept “FSA/HSA cards” alongside credit cards and insurance[3].
Zepbound is Lilly's brand of tirzepatide, and the harder questions are about insurance, not the account. Lilly sells it self-pay and through insurance, and each route carries its own terms. This page sets those terms side by side, as published. What each dose costs is in the Zepbound price guide.
What Lilly’s page says, presentation by presentation
Zepbound comes as a single-dose vial, a four-dose KwikPen and a single-dose pen, and Lilly gives each one its own payment line[2]. The HSA line is the same under all three. The insurance line is not.
| Presentation | Payment line on Lilly's page | HSA/FSA line on Lilly's page |
|---|---|---|
| Single-dose vial | Exclusively available through LillyDirect; self-pay only | Eligible; eligibility may vary by plan |
| KwikPen | Select insurance accepted; self-pay accepted | Eligible; eligibility may vary by plan |
| Single-dose pen | Insurance accepted | Eligible; eligibility may vary by plan |
So the account question has one answer across the range, and the insurance question has three. The vial is the only presentation with no insurance route at all[2].
What the IRS asks before an HSA can pay
An HSA pays tax-free for “qualified medical expenses”, which the IRS defines through medical care under Code section 213(d)[4]. It adds a limit: only to the extent the amounts are not compensated for by insurance or otherwise[4].
For a drug, the IRS counts prescribed medicines, meaning one that requires a prescription by a doctor for its use[5]. For weight loss, the cost must treat a specific disease a physician diagnosed, such as obesity, hypertension or heart disease[5]. Weight loss for appearance or general health does not count[5].
Lilly does not say what varies by plan. The IRS test turns on the prescription and the diagnosis behind it, so keep both with each receipt. The IRS tests for all peptides are walked through in can you use an HSA for peptides.
Self-pay and your insurance: the agreement you make
LillyDirect lets an insured patient choose self-pay for any medicine[3]. The FAQ attaches one condition: you “agree not to seek reimbursement from your insurance or any third-party payer”[3]. On the self-pay route, the FAQ adds, no prior authorization is needed[3].
The KwikPen self-pay card spells the deal out further. You agree not to seek or accept reimbursement from any insurance plan, “healthcare reimbursement account”, or other third-party payer[1]. You also agree not to apply those costs toward your “deductible or true out-of-pocket obligations”[1].
| Program | HSA, FSA or reimbursement account | Deductible |
|---|---|---|
| Journey Program (vial, and KwikPen self-pay) | No clause in the purchase-offer terms | No clause in the purchase-offer terms |
| KwikPen Self-Pay Savings Card | No reimbursement from any "healthcare reimbursement account" for out-of-pocket costs | Costs may not be applied toward a deductible or true out-of-pocket obligation |
| Commercial savings card (pen, KwikPen) | No reimbursement from an HSA or FSA for the amount of the savings | Lilly may cut savings if the plan does not credit card payments |
The phrase to ask about before paying
Two Lilly texts sit close together here. The FAQ says LillyDirect takes HSA cards at checkout[3]. The KwikPen self-pay card terms rule out reimbursement from a “healthcare reimbursement account”[1]. The terms do not define that phrase.
Paying at checkout with the HSA card is the route LillyDirect describes. Paying by credit card and reimbursing yourself from the HSA later is the route the phrase could reach. If you plan the second, ask LillyDirect first. Its number is on the Zepbound page[2].
Does a self-pay fill count toward your deductible?
On the KwikPen self-pay card, no: its terms bar applying the cost toward a deductible[1]. For the vial, the Journey Program terms carry no deductible clause either way[1]. They do not need one in practice. The vial is self-pay only, so no claim goes to your plan[2].
Whether a plan would credit a receipt you send it is the plan’s rule, not Lilly’s. Ask the plan before counting on it. The refill rule that sets the vial price is in the Zepbound Self Pay Journey Program.
With the commercial savings card
The commercial card works alongside insurance, on the single-dose pen or the KwikPen[1]. Its HSA clause is narrower. You may not seek reimbursement from a health savings or flexible spending account “for any amount of the savings received through the Card”[1].
So the HSA can pay what you paid, but not the discount Lilly covered. The card also names a deductible risk. Lilly may cut the savings if your plan does not apply card payments to your deductible or coinsurance[1]. What the card pays in each case is in the Zepbound savings card guide.
Keeping the account and the tax return apart
An amount paid from an HSA cannot also be deducted as an itemized medical expense[4]. The deduction side, with its 7.5% floor, is in is Zepbound tax deductible.
Novo Nordisk runs its own cash pharmacy for Wegovy on different terms, set out in NovoCare Pharmacy Wegovy. Compounded tirzepatide is a separate purchase with its own receipts, priced on the tirzepatide price board.